Back to top

Image: Bigstock

New Strong Buy Stocks for May 28th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

Tech Data Corporation (TECD - Free Report) : This company that operates as an IT distribution and solutions company has seen the Zacks Consensus Estimate for its current year earnings increasing 1% over the last 60 days.

Acuity Brands, Inc. (AYI - Free Report) : This company that provides lighting and building management solutions and services has seen the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

Acuity Brands Inc Price and Consensus

 

Acuity Brands Inc Price and Consensus

Acuity Brands Inc price-consensus-chart | Acuity Brands Inc Quote

Cactus, Inc. (WHD - Free Report) : This company that designs, manufactures, sells, and rents a range of wellheads and pressure control equipment has seen the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

Cactus, Inc. Price and Consensus

 

Cactus, Inc. Price and Consensus

Cactus, Inc. price-consensus-chart | Cactus, Inc. Quote

Equitrans Midstream Corporation (ETRN - Free Report) : This company that owns, operates, acquires, and develops natural gas has seen the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.

NXP Semiconductors N.V. (NXPI - Free Report) : This semiconductor company has seen the Zacks Consensus Estimate for its current year earnings increasing 5.8% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>